Spatial Genomics & Transcriptomics Market Size, Share, Trends, Industry Analysis Report: By Technique, Product (Instrument, Consumables, and Software), Application, End User, and Region; Market Forecast, 2025

Description

List of Tables

The global spatial genomics & transcriptomics market size is expected to reach USD 2,399.32 million by 2034, according to a new study by Polaris Market Research. The report "Spatial Genomics & Transcriptomics Market Size, Share, Trends, Industry Analysis Report: By Technique, Product (Instrument, Consumables, and Software), Application, End User, and Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The spatial genomics and transcriptomics market has emerged as a critical frontier in biomedical research, driven by the increasing demand for personalized medicine and the need for advanced understanding of complex diseases, particularly cancer. Spatial genomics refers to the techniques used to map gene expression within the spatial context of tissue architecture. In contrast, spatial transcriptomics focuses specifically on the localization of RNA within tissue samples. This bridges molecular biology and histology, allowing researchers to capture the intricate relationships between cellular components in their native environments.

Increasing cancer incidence is further fostering research on cell and gene therapies, which in turn is creating significant investments in the spatial genomics and transcriptomics market. As per the World Health Organization report, more than 35 million cases are expected to be registered by 2050, which is a rise of 77% from 2022.

The applications of spatial genomics and transcriptomics extend to a wide range of diseases, including neurological disorders, cardiovascular diseases, and autoimmune conditions. For instance, in neurobiology, understanding the spatial distribution of gene expression in brain tissues can uncover the mechanisms underlying neurodegenerative diseases such as Alzheimer's and Parkinson's. This has prompted pharmaceutical companies and research institutions to invest heavily in spatial genomics technologies as they seek to develop targeted therapies that effectively address these complex conditions.

Spatial Genomics & Transcriptomics Market Report Highlights

The spatial genomics segment is anticipated to witness the highest growth over the forecast period due to its critical role in understanding complex diseases, particularly cancer.

In 2024, the spatial transcriptomics segment accounted for the largest spatial genomics & transcriptomics market share, owing to its ability to provide rich information about gene expression at a cellular level while retaining spatial information.

The translational research segment accounted for the largest revenue share in the market in 2024 due to its crucial role in bridging the gap between laboratory discoveries and clinical applications.

APAC is projected to register the fastest growth over the forecast period due to rapidly advancing capabilities in genomics and transcriptomics, supported by substantial government initiatives aimed at enhancing healthcare and biotechnology.

The global players include 10X Genomics; Akoya Biosciences, Inc.; Bio-Rad Laboratories; Bio-Techne Corporation; BioSpyder Technologies Inc.; Cantata Bio; Danaher Corporation; Genomic Vision SA; Illumina; Lunaphore Technologies SA; Miltenyi Biotec; NanoString Technologies, Inc.; Natera, Inc.; and Optical Biosystems Inc.

Polaris Market Research has segmented the spatial genomics & transcriptomics market report based on technique, product, application, end user, and region:

By Technique Outlook (Revenue, USD Million, 2020 - 2034)

Spatial Genomics
Immunohistochemistry (IHC)
In Situ Hybridization
Sequencing Techniques
Microscopy-based RNA imaging
Other Spatial Genomics Techniques
Spatial Transcriptomics
Immunohistochemistry (IHC)
In Situ Hybridization
Sequencing Techniques
Other Spatial Transcriptomics Techniques

By Product Outlook (Revenue, USD Million, 2020 - 2034)

Instruments
Consumables
Software

By Application Outlook (Revenue, USD Million, 2020 - 2034)

Translational Research
Drug Discovery and Development

By End User Outlook (Revenue, USD Million, 2020 - 2034)

Academic Research Institutes
Contract Research Organizations
Pharmaceutical and Biotechnology Companies

By Region Outlook (Revenue, USD Million, 2020 - 2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

Product Code: PM5203

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Techniques
- 3.2.1. Primary Techniques
- 3.2.2. Secondary Techniques

4. Global Spatial Genomics & Transcriptomics Market Insights

4.1. Spatial Genomics & Transcriptomics Market - Market Snapshot
4.2. Spatial Genomics & Transcriptomics Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising prevalence of cancer is driving the spatial genomics & transcriptomics market.
  - 4.2.1.2. Introduction of the fourth generation of sequencing is propelling the spatial genomics & transcriptomics market.
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High costs and complex data analysis are hampering the global market.
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Spatial Genomics & Transcriptomics Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Spatial Genomics & Transcriptomics Market, by Technique

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
5.3. Spatial Genomics
- 5.3.1. Global Spatial Genomics & Transcriptomics Market, by Spatial Genomics, by Region, 2020-2034 (USD Million)
  - 5.3.1.1. Immunohistochemistry (IHC)
  - 5.3.1.1.1. Global Spatial Genomics & Transcriptomics Market, by Immunohistochemistry (IHC), by Region, 2020-2034 (USD Million)
  - 5.3.1.2. In Situ Hybridization
  - 5.3.1.2.1. Global Spatial Genomics & Transcriptomics Market, by In Situ Hybridization, by Region, 2020-2034 (USD Million)
  - 5.3.1.3. Sequencing Techniques
  - 5.3.1.3.1. Global Spatial Genomics & Transcriptomics Market, by Sequencing Techniques, by Region, 2020-2034 (USD Million)
  - 5.3.1.4. Microscopy based RNA imaging
  - 5.3.1.4.1. Global Spatial Genomics & Transcriptomics Market, by Microscopy based RNA imaging, by Region, 2020-2034 (USD Million)
  - 5.3.1.5. Other Spatial Transcriptomics Techniques
  - 5.3.1.5.1. Global Spatial Genomics & Transcriptomics Market, by Other Spatial Genomics Techniques, by Region, 2020-2034 (USD Million)
5.4. Spatial Transcriptomics
- 5.4.1. Global Spatial Genomics & Transcriptomics Market, by Spatial Transcriptomics, by Region, 2020-2034 (USD Million)
  - 5.4.1.1. Immunohistochemistry (IHC)
  - 5.4.1.1.1. Global Spatial Genomics & Transcriptomics Market, by Immunohistochemistry (IHC), by Region, 2020-2034 (USD Million)
  - 5.4.1.2. In Situ Hybridization
  - 5.4.1.2.1. Global Spatial Genomics & Transcriptomics Market, by In Situ Hybridization, by Region, 2020-2034 (USD Million)
  - 5.4.1.3. Sequencing Techniques
  - 5.4.1.3.1. Global Spatial Genomics & Transcriptomics Market, by Sequencing Techniques, by Region, 2020-2034 (USD Million)
  - 5.4.1.4. Other Spatial Transcriptomics Techniques
  - 5.4.1.4.1. Global Spatial Genomics & Transcriptomics Market, by Other Spatial Transcriptomics Techniques, by Region, 2020-2034 (USD Million)

6. Global Spatial Genomics & Transcriptomics Market, by Product

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
6.3. Instruments
- 6.3.1. Global Spatial Genomics & Transcriptomics Market, by Instruments, by Region, 2020-2034 (USD Million)
6.4. Consumables
- 6.4.1. Global Spatial Genomics & Transcriptomics Market, by Consumables, by Region, 2020-2034 (USD Million)
6.5. Software
- 6.5.1. Global Spatial Genomics & Transcriptomics Market, by Software, by Region, 2020-2034 (USD Million)

7. Global Spatial Genomics & Transcriptomics Market, by Application

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
7.3. Translational Research
- 7.3.1. Global Spatial Genomics & Transcriptomics Market, by Translational Research, by Region, 2020-2034 (USD Million)
7.4. Drug Discovery and Development
- 7.4.1. Global Spatial Genomics & Transcriptomics Market, by Drug Discovery and Development, by Region, 2020-2034 (USD Million)

8. Global Spatial Genomics & Transcriptomics Market, by End User

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
8.3. Academic Research Institutes
- 8.3.1. Global Spatial Genomics & Transcriptomics Market, by Academic Research Institutes, by Region, 2020-2034 (USD Million)
8.4. Contract Research Organizations
- 8.4.1. Global Spatial Genomics & Transcriptomics Market, by Contract Research Organizations, by Region, 2020-2034 (USD Million)
8.5. Pharmaceutical and Biotechnology Companies
- 8.5.1. Global Spatial Genomics & Transcriptomics Market, by Pharmaceutical and Biotechnology Companies, by Region, 2020-2034 (USD Million)

9. Global Spatial Genomics & Transcriptomics Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Spatial Genomics & Transcriptomics Market Assessment, By Geography, 2020-2034 (USD Million)
9.3. Spatial Genomics & Transcriptomics Market - North America
- 9.3.1. North America: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
- 9.3.2. North America: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
- 9.3.3. North America: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
- 9.3.4. North America: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.3.5. Spatial Genomics & Transcriptomics Market - US
  - 9.3.5.1. US: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.3.5.2. US: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.3.5.3. US: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.3.5.4. US: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.3.6. Spatial Genomics & Transcriptomics Market - Canada
  - 9.3.6.1. Canada: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.3.6.2. Canada: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.3.6.3. Canada: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.3.6.4. Canada: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
9.4. Spatial Genomics & Transcriptomics Market - Europe
- 9.4.1. Europe: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
- 9.4.2. Europe: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
- 9.4.3. Europe: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
- 9.4.4. Europe: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.4.5. Spatial Genomics & Transcriptomics Market - UK
  - 9.4.5.1. UK: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.4.5.2. UK: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.4.5.3. UK: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.4.5.4. UK: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.4.6. Spatial Genomics & Transcriptomics Market - France
  - 9.4.6.1. France: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.4.6.2. France: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.4.6.3. France: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.4.6.4. France: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.4.7. Spatial Genomics & Transcriptomics Market - Germany
  - 9.4.7.1. Germany: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.4.7.2. Germany: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.4.7.3. Germany: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.4.7.4. Germany: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.4.8. Spatial Genomics & Transcriptomics Market - Italy
  - 9.4.8.1. Italy: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.4.8.2. Italy: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.4.8.3. Italy: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.4.8.4. Italy: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.4.9. Spatial Genomics & Transcriptomics Market - Spain
  - 9.4.9.1. Spain: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.4.9.2. Spain: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.4.9.3. Spain: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.4.9.4. Spain: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.4.10. Spatial Genomics & Transcriptomics Market - Netherlands
  - 9.4.10.1. Netherlands: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.4.10.2. Netherlands: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.4.10.3. Netherlands: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.4.10.4. Netherlands: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.4.11. Spatial Genomics & Transcriptomics Market - Russia
  - 9.4.11.1. Russia: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.4.11.2. Russia: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.4.11.3. Russia: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.4.11.4. Russia: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.4.12. Spatial Genomics & Transcriptomics Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.4.12.2. Rest of Europe: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.4.12.3. Rest of Europe: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.4.12.4. Rest of Europe: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
9.5. Spatial Genomics & Transcriptomics Market - Asia Pacific
- 9.5.1. Asia Pacific: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
- 9.5.2. Asia Pacific: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
- 9.5.3. Asia Pacific: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
- 9.5.4. Asia Pacific: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.5.5. Spatial Genomics & Transcriptomics Market - China
  - 9.5.5.1. China: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.5.5.2. China: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.5.5.3. China: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.5.5.4. China: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.5.6. Spatial Genomics & Transcriptomics Market - India
  - 9.5.6.1. India: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.5.6.2. India: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.5.6.3. India: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.5.6.4. India: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.5.7. Spatial Genomics & Transcriptomics Market - Malaysia
  - 9.5.7.1. Malaysia: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.5.7.2. Malaysia: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.5.7.3. Malaysia: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.5.7.4. Malaysia: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.5.8. Spatial Genomics & Transcriptomics Market - Japan
  - 9.5.8.1. Japan: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.5.8.2. Japan: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.5.8.3. Japan: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.5.8.4. Japan: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.5.9. Spatial Genomics & Transcriptomics Market - Indonesia
  - 9.5.9.1. Indonesia: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.5.9.2. Indonesia: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.5.9.3. Indonesia: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.5.9.4. Indonesia: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.5.10. Spatial Genomics & Transcriptomics Market - South Korea
  - 9.5.10.1. South Korea: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.5.10.2. South Korea: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.5.10.3. South Korea: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.5.10.4. South Korea: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.5.11. Spatial Genomics & Transcriptomics Market - Australia
  - 9.5.11.1. Australia: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.5.11.2. Australia: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.5.11.3. Australia: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.5.11.4. Australia: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.5.12. Spatial Genomics & Transcriptomics Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.5.12.2. Rest of Asia Pacific: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.5.12.3. Rest of Asia Pacific: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.5.12.4. Rest of Asia Pacific: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
9.6. Spatial Genomics & Transcriptomics Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
- 9.6.2. Middle East & Africa: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
- 9.6.3. Middle East & Africa: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
- 9.6.4. Middle East & Africa: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.6.5. Spatial Genomics & Transcriptomics Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.6.5.2. Saudi Arabia: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.6.5.3. Saudi Arabia: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.6.5.4. Saudi Arabia: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.6.6. Spatial Genomics & Transcriptomics Market - UAE
  - 9.6.6.1. UAE: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.6.6.2. UAE: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.6.6.3. UAE: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.6.6.4. UAE: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.6.7. Spatial Genomics & Transcriptomics Market - Israel
  - 9.6.7.1. Israel: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.6.7.2. Israel: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.6.7.3. Israel: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.6.7.4. Israel: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.6.8. Spatial Genomics & Transcriptomics Market - South Africa
  - 9.6.8.1. South Africa: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.6.8.2. South Africa: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.6.8.3. South Africa: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.6.8.4. South Africa: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.6.9. Spatial Genomics & Transcriptomics Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.6.9.2. Rest of Middle East & Africa: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.6.9.3. Rest of Middle East & Africa: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.6.9.4. Rest of Middle East & Africa: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
9.7. Spatial Genomics & Transcriptomics Market - Latin America
- 9.7.1. Latin America: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
- 9.7.2. Latin America: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
- 9.7.3. Latin America: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
- 9.7.4. Latin America: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.7.5. Spatial Genomics & Transcriptomics Market - Mexico
  - 9.7.5.1. Mexico: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.7.5.2. Mexico: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.7.5.3. Mexico: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.7.5.4. Mexico: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.7.6. Spatial Genomics & Transcriptomics Market - Brazil
  - 9.7.6.1. Brazil: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.7.6.2. Brazil: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.7.6.3. Brazil: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.7.6.4. Brazil: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.7.7. Spatial Genomics & Transcriptomics Market - Argentina
  - 9.7.7.1. Argentina: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.7.7.2. Argentina: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.7.7.3. Argentina: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.7.7.4. Argentina: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)
- 9.7.8. Spatial Genomics & Transcriptomics Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: Spatial Genomics & Transcriptomics Market, by Technique, 2020-2034 (USD Million)
  - 9.7.8.2. Rest of Latin America: Spatial Genomics & Transcriptomics Market, by Product, 2020-2034 (USD Million)
  - 9.7.8.3. Rest of Latin America: Spatial Genomics & Transcriptomics Market, by Application, 2020-2034 (USD Million)
  - 9.7.8.4. Rest of Latin America: Spatial Genomics & Transcriptomics Market, by End User, 2020-2034 (USD Million)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. 10X Genomics
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Akoya Biosciences, Inc.
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Bio-Rad Laboratories
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. Bio-Techne Corporation
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. BioSpyder Technologies Inc.
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. Cantata Bio
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. Danaher Corporation
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. Genomic Vision SA
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Illumina
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Lunaphore Technologies SA
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. Miltenyi Biotec
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. NanoString Technologies, Inc.
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
11.13. Natera, Inc.
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
11.14. Optical Biosystems Inc.
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development